OBJECTIVES: The purpose of this observational study was to evaluate the effects of radial artery access versus femoral artery access on the risk of 30-day mortality, inhospital bleeding and cardiogenic shock in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. METHODS: We used data from the SWEDEHEART registry and included all patients who were treated with primary percutaneous coronary intervention in Sweden between 2005 and 2016. We compared patients who had percutaneous coronary intervention by radial access versus femoral access with regard to the primary endpoint of all-cause death within 30 days, using a multilevel propensity score adjusted logistic regression which included hospital as a random effect. RESULTS: During the study period, 44,804 patients underwent primary percutaneous coronary intervention of whom 24,299 (54.2%) had radial access and 20,505 (45.8%) femoral access. There were 2487 (5.5%) deaths within 30 days, of which 920 (3.8%) occurred in the radial access and 1567 (7.6%) in the femoral access group. After propensity score adjustment, radial access was associated with a lower risk of death (adjusted odds ratio (OR) 0.70, 95% confidence interval (CI) 0.55-0.88, P = 0.025). We found no interaction between access site and age, gender and cardiogenic shock regarding 30-day mortality. Radial access was also associated with a lower adjusted risk of bleeding (adjusted OR 0.45, 95% CI 0.25-0.79, P = 0.006) and cardiogenic shock (adjusted OR 0.41, 95% CI 0.24-0.73, P = 0.002). CONCLUSIONS: In patients with ST-elevation myocardial infarction, primary percutaneous coronary intervention by radial access rather than femoral access was associated with an adjusted lower risk of death, bleeding and cardiogenic shock. Our findings are consistent with, and add external validity to, recent randomised trials.
OBJECTIVES: The purpose of this observational study was to evaluate the effects of radial artery access versus femoral artery access on the risk of 30-day mortality, inhospital bleeding and cardiogenic shock in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. METHODS: We used data from the SWEDEHEART registry and included all patients who were treated with primary percutaneous coronary intervention in Sweden between 2005 and 2016. We compared patients who had percutaneous coronary intervention by radial access versus femoral access with regard to the primary endpoint of all-cause death within 30 days, using a multilevel propensity score adjusted logistic regression which included hospital as a random effect. RESULTS: During the study period, 44,804 patients underwent primary percutaneous coronary intervention of whom 24,299 (54.2%) had radial access and 20,505 (45.8%) femoral access. There were 2487 (5.5%) deaths within 30 days, of which 920 (3.8%) occurred in the radial access and 1567 (7.6%) in the femoral access group. After propensity score adjustment, radial access was associated with a lower risk of death (adjusted odds ratio (OR) 0.70, 95% confidence interval (CI) 0.55-0.88, P = 0.025). We found no interaction between access site and age, gender and cardiogenic shock regarding 30-day mortality. Radial access was also associated with a lower adjusted risk of bleeding (adjusted OR 0.45, 95% CI 0.25-0.79, P = 0.006) and cardiogenic shock (adjusted OR 0.41, 95% CI 0.24-0.73, P = 0.002). CONCLUSIONS: In patients with ST-elevation myocardial infarction, primary percutaneous coronary intervention by radial access rather than femoral access was associated with an adjusted lower risk of death, bleeding and cardiogenic shock. Our findings are consistent with, and add external validity to, recent randomised trials.
Authors: Judith Kooiman; Milan Seth; Brahmajee K Nallamothu; Michael Heung; David Humes; Hitinder S Gurm Journal: Circ Cardiovasc Interv Date: 2015-06 Impact factor: 6.546
Authors: Martial Hamon; Christian Pristipino; Carlo Di Mario; James Nolan; Josef Ludwig; Marco Tubaro; Manel Sabate; Josepa Mauri-Ferré; Kurt Huber; Kari Niemelä; Michael Haude; William Wijns; Dariusz Dudek; Jean Fajadet; Ferdinand Kiemeneij Journal: EuroIntervention Date: 2013-03 Impact factor: 6.534
Authors: Giuseppe Andò; Bernardo Cortese; Filippo Russo; Martina Rothenbühler; Enrico Frigoli; Giuseppe Gargiulo; Carlo Briguori; Pascal Vranckx; Sergio Leonardi; Vincenzo Guiducci; Flavia Belloni; Fabio Ferrari; Jose Maria de la Torre Hernandez; Salvatore Curello; Francesco Liistro; Andrea Perkan; Stefano De Servi; Gavino Casu; Antonio Dellavalle; Dionigi Fischetti; Antonio Micari; Bruno Loi; Fabio Mangiacapra; Nunzio Russo; Fabio Tarantino; Francesco Saia; Dik Heg; Stephan Windecker; Peter Jüni; Marco Valgimigli Journal: J Am Coll Cardiol Date: 2017-05-11 Impact factor: 24.094
Authors: Marco Valgimigli; Andrea Gagnor; Paolo Calabró; Enrico Frigoli; Sergio Leonardi; Tiziana Zaro; Paolo Rubartelli; Carlo Briguori; Giuseppe Andò; Alessandra Repetto; Ugo Limbruno; Bernardo Cortese; Paolo Sganzerla; Alessandro Lupi; Mario Galli; Salvatore Colangelo; Salvatore Ierna; Arturo Ausiello; Patrizia Presbitero; Gennaro Sardella; Ferdinando Varbella; Giovanni Esposito; Andrea Santarelli; Simone Tresoldi; Marco Nazzaro; Antonio Zingarelli; Nicoletta de Cesare; Stefano Rigattieri; Paolo Tosi; Cataldo Palmieri; Salvatore Brugaletta; Sunil V Rao; Dik Heg; Martina Rothenbühler; Pascal Vranckx; Peter Jüni Journal: Lancet Date: 2015-03-16 Impact factor: 79.321
Authors: Adnan K Chhatriwalla; Amit P Amin; Kevin F Kennedy; John A House; David J Cohen; Sunil V Rao; John C Messenger; Steven P Marso Journal: JAMA Date: 2013-03-13 Impact factor: 56.272
Authors: Jason B Lindsey; Steven P Marso; Michael Pencina; Joshua M Stolker; Kevin F Kennedy; Charanjit Rihal; Greg Barsness; Robert N Piana; Steven L Goldberg; Donald E Cutlip; Neal S Kleiman; David J Cohen Journal: JACC Cardiovasc Interv Date: 2009-11 Impact factor: 11.195
Authors: Andrew Mitchell; Takeshi Fujisawa; Nicholas L Mills; Mairi Brittan; David E Newby; Nicholas L M Cruden Journal: J Am Heart Assoc Date: 2017-10-28 Impact factor: 5.501
Authors: Tobias Roeschl; Anas M Jano; Franziska Fochler; Mona M Grewe; Marlis Wacker; Kirstin Meier; Christian Schmidt; Lars Maier; Peter H Grewe Journal: Sci Rep Date: 2022-07-29 Impact factor: 4.996